BioCentury
ARTICLE | Distillery Techniques

Drug platforms

April 10, 2018 11:02 PM UTC

HSPCs derived from iPS cells and engineered to express the MLL-AF4 fusion oncogene could improve the engraftment of HSPC transplant therapies. The HSPCs were generated by inducing differentiation of i...